Posted inGenetics
ALS Drug Extends Survival in Mice, Targets TDP-43 Low-Complexity Domain
Credit: BlackJack3D / E+ / Getty Images In a new study published in Nature Aging titled, “Therapeutic targeting of the conserved region within…
Posted inBiotechnology
Fibronectin Overactivation Drives Marfan Aortic Disease
A quiet revolution is unfolding in the understanding of Marfan syndrome, a genetic disorder that stealthily sabotages the body’s connective…
Posted inBiotechnology
Bacteria evolve faster with unconventional gene copies
In the perpetual arms race between humans and microbes, bacteria have consistently demonstrated an uncanny ability to circumvent our most…
Posted inBiotechnology
Neighbours rewire soil feedback via root microbiome shifts
In a revelation that fundamentally reshapes our understanding of how plants interact, a team of researchers has discovered that the…
Posted inBiotechnology
Laser Lancing Non-Inferior to Heel Prick for Preemies
The sting of a heel lance is, for most of humanity, our very first encounter with pain. It arrives not…
Posted inBiotechnology
De Jong Gierveld Scale validated for Portuguese seniors
In a sunlit apartment overlooking the red-tiled rooftops of Lisbon, an 82-year-old woman named Maria arranges a single plate for…
Posted inMedical Technology
NICE recommends Endosure and Endotest diagnostics for endometriosis
Women in England are set to gain new, taxpayer-funded tests for endometriosis after NICE recommended them for regular use.
Posted inBiotechnology
Novartis to pay $1.1B upfront for UK biotech Myricx to expand the pharma’s ADC pipeline
Novartis is pushing deeper into antibody-drug conjugate development, paying $1.1 billion upfront to buy Myricx Bio for a pipeline based…
Posted inGenetics
StockWatch: New UC Data Sparks Smoother Sailing for Abivax
A graphic image of Abivax’s lead pipeline candidate obefazimod, a small molecule upregulator of miR-124, an anti-inflammatory microRNA. Less than…
Posted inBiotechnology
Genentech lays off 103 alongside gRED rethink, pens $490M breast cancer collab
A month after Genentech confirmed the restructuring of its early development group, the Roche subsidiary has now disclosed that this…